利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

14 条记录 (耗时 0.015 秒)

    Use Of Minoxidil Sulfate As An Anti-Tumor Drug
    1.
    发明申请
    Use Of Minoxidil Sulfate As An Anti-Tumor Drug 失效
    使用硫酸米诺地尔作为抗肿瘤药物

    公开(公告)号：US20080207657A1

    公开(公告)日：2008-08-28

    申请号：US11813461

    申请日：2006-02-22

    申请人： Keith L. Black ,  Christopher Wheeler

    发明人： Keith L. Black ,  Christopher Wheeler

    IPC分类号： A61K31/506 ,  A61K31/4409 ,  A61P35/04

    CPC分类号： A61K31/44 ,  A61K31/506 ,  A61K39/0011 ,  A61K45/06 ,  A61K2300/00

    摘要： The invention relates to compositions, methods and kits for the treatment of cancer. ATP-dependent potassium channel agonists, salts thereof, or chemical analogs thereof, for example, minoxidil sulfate, have been found to possess anti-neoplastic properties. Administering minoxidil sulfate may prolong the life of a cancer patient; for example, a patient with a brain tumor.

    摘要翻译： 本发明涉及用于治疗癌症的组合物，方法和试剂盒。 已经发现ATP依赖性钾通道激动剂，其盐或其化学类似物，例如硫酸米诺地尔，具有抗肿瘤性质。 施用硫酸米诺地尔可延长癌症患者的寿命; 例如，患有脑肿瘤的患者。

    Private network access point router for interconnecting among internet route providers
    2.
    发明申请
    Private network access point router for interconnecting among internet route providers 审中-公开
    专用网络接入点路由器，用于互联网路由提供商之间的互连

    公开(公告)号：US20050201365A1

    公开(公告)日：2005-09-15

    申请号：US11126575

    申请日：2005-05-10

    申请人： Christopher Wheeler ,  Ophir Ronen ,  Benjamin Black ,  Michael McMillin ,  John Carlson

    发明人： Christopher Wheeler ,  Ophir Ronen ,  Benjamin Black ,  Michael McMillin ,  John Carlson

    IPC分类号： H04L12/28 ,  H04L12/46 ,  H04L12/56 ,  H04L29/06 ,  H04Q11/04 ,  H04L12/66

    CPC分类号： H04L12/2872 ,  H04L12/2856 ,  H04L29/06 ,  H04L45/00 ,  H04L45/02 ,  H04L2012/562 ,  H04L2012/5621 ,  H04Q11/0478

    摘要： An improvement to the Private Network Access Point (PNAP) packet switched network described in U.S. Pat. No. 6,009,081, where two customers connected to the same PNAP will exchange traffic through the PNAP without transiting over the backbones of the Internet. In addition, a multi-homed customer connected to the PNAP is provided with access to the PNAP optimized routing table so that the customer will also have the ability to know the best route for a particular destination. In this way, if a multi-homed customer connected to the PNAP is directly connected to a particular NSP to which a destination is also connected, the PNAP customer can use the PNAP information regarding the NSP to send the information to the destination through that commonly connected NSP in the most direct fashion.

    摘要翻译： 对美国专利中描述的专用网络接入点（PNAP）分组交换网络的改进。 6,009,081号，其中连接到同一个PNAP的两个客户将通过PNAP交换流量，而无需通过互联网的主干。 此外，连接到PNAP的多宿主客户可以访问PNAP优化的路由表，以便客户也能够知道特定目的地的最佳路由。 以这种方式，如果连接到PNAP的多宿主客户直接连接到目的地也连接到的特定NSP，则PNAP客户可以使用关于NSP的PNAP信息通过通常的方式将信息发送到目的地 以最直接的方式连接NSP。

    Methods and systems for controlling network infrastructure devices
    3.
    发明申请
    Methods and systems for controlling network infrastructure devices 审中-公开
    用于控制网络基础设施设备的方法和系统

    公开(公告)号：US20050004942A1

    公开(公告)日：2005-01-06

    申请号：US10817157

    申请日：2004-04-02

    申请人： Mark Madsen ,  Christopher Wheeler ,  Shaw Chuang ,  Timothy Hinderliter ,  Alx Dark ,  Christine Windsor

    发明人： Mark Madsen ,  Christopher Wheeler ,  Shaw Chuang ,  Timothy Hinderliter ,  Alx Dark ,  Christine Windsor

    IPC分类号： G06F20060101 ,  G06F7/00 ,  G06F17/30 ,  H04L12/24

    CPC分类号： H04L41/0856 ,  H04L41/0843 ,  H04L41/0853 ,  H04L41/0893

    摘要： A network management system is provided that allows a user to configure multiple devices according to a consistent set of policies. The system includes a device learning module that can read configuration data from a network device and automatically match that configuration data to existing policies and components of policies within the system. The device learning module also identifies unknown configuration data, which does not match any existing policy. The system further includes a grammar builder that can parse the unknown configuration data and construct a component or policy from the unknown data, by matching the unknown data to a grammar of configuration commands for the network device. The system also provided auditing capabilities, where policies are compared to running network configurations, and differences are identified.

    摘要翻译： 提供了一种网络管理系统，其允许用户根据一套一致的策略配置多个设备。 该系统包括一个设备学习模块，可以从网络设备读取配置数据，并自动将该配置数据与系统中现有的策略和策略组件进行匹配。 设备学习模块还识别未知配置数据，这与现有策略不匹配。 该系统还包括语法构建器，其可以通过将未知数据与网络设备的配置命令的语法相匹配来解析未知配置数据并从未知数据构建组件或策略。 该系统还提供审计功能，将策略与运行的网络配置进行比较，并确定差异。

    System and method for the treatment of cancer, including cancers of the central nervous system
    9.
    发明授权
    System and method for the treatment of cancer, including cancers of the central nervous system 有权
    用于治疗癌症的系统和方法，包括中枢神经系统的癌症

    公开(公告)号：US07939090B2

    公开(公告)日：2011-05-10

    申请号：US10575438

    申请日：2004-10-20

    申请人： Christopher Wheeler ,  Asha Das ,  Keith L. Black

    发明人： Christopher Wheeler ,  Asha Das ,  Keith L. Black

    IPC分类号： A61K39/00

    CPC分类号： A61K45/06 ,  A61K31/203 ,  A61K31/282 ,  A61K31/454 ,  A61K31/4745 ,  A61K31/704 ,  A61K31/7048 ,  A61K33/24 ,  A61K39/00 ,  A61K39/0011 ,  A61K2039/5154 ,  A61K2300/00

    摘要： The invention relates to the treatment of cancer, and particularly to the treatment of cancers of the central nervous system, such as glioblastoma multiforme. A dual therapeutic approach is provided, including the administration of a dendritic cell-based cancer vaccine and a regimen of chemotherapy. The two therapies may be administered concurrently with one another and/or with an initial vaccination preceding chemotherapy. In various embodiments, the dendritic cell-based cancer vaccine includes either primed or unprimed dendritic cells; for instance, the dendritic cells may be autologous tumor antigen-presented dendritic cells. The dual therapeutic approach of the instant invention beneficially influences the chemosensitivity of a mammal with cancer.

    摘要翻译： 本发明涉及癌症的治疗，特别涉及治疗中枢神经系统的癌症，例如多形性成胶质细胞瘤。 提供了双重治疗方法，包括施用基于树突状细胞的癌症疫苗和化学疗法。 两种疗法可以彼此同时施用和/或在化学疗法之前进行初次接种。 在各种实施方案中，基于树突状细胞的癌症疫苗包括引发或未引发的树突状细胞; 例如，树突状细胞可以是自体肿瘤抗原呈递的树突状细胞。 本发明的双重治疗方法有益地影响具有癌症的哺乳动物的化学敏感性。